$ Value
$0
Shares
80,000
Price
$0
Filed
Jul 3
Insider
Name
PROEHL GERALD T
Title
—
CIK
0001279191
Roles
Transaction Details
Transaction Date
2025-07-01
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
80,000
Footnotes
The pre-funded warrant has no expiration date. | The warrant will expire on the earlier of (i) thirty (30) trading days following the date of the Issuer's initial public announcement of topline data from its Phase 3 LEVEL Study (LEVosimendan to Improve Exercise Limitation in PH-HFpEF Patients) (NCT05983250 ) (the "Topline Data Announcement"); (ii) proportionally upon the exercise of the Reporting Person's pre-funded warrant issued on August 8, 2024, if such exercise is prior to the Topline Data Announcement; and (iii) August 8, 2029.
Filing Info
PROEHL GERALD T's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-09 | TENX | A | $0 |
| 2026-01-02 | DRMA | A | $0 |
| 2025-12-23 | DRMA | A | — |
| 2025-12-23 | DRMA | A | — |
| 2025-12-23 | DRMA | A | — |
| 2025-12-23 | DRMA | A | — |
| 2025-12-23 | DRMA | A | — |
| 2025-12-23 | DRMA | A | — |
| 2025-12-23 | DRMA | D | — |
| 2025-12-23 | DRMA | A | — |
Other Insiders at TENX (90d)
No other insider activity at this issuer in the last 90 days.